Organization | Universidad del Desarrollo

Universidad del Desarrollo Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Concepción Chile (1990)

Organization Overview

First Clinical Trial

2003

NCT00128180

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Florencia Pacheco | Universidad del Desarrollo

Active Ingredients

Drugs in Phase 4 Trials (2)

progesterone (progestasert) (1 trial)

propofol (diprivan) (3 trials)

Drugs in Phase 3 Trials (1)

atorvastatin (lipitor) (1 trial)

Drugs in Phase 2 Trials (4)

allogeneic bone marrow derived mesenchymal stem cell (1 trial)

bnt162b2 (1 trial)

inactivated SARS-Cov-2 vaccine (1 trial)

methylprednisolone (medrol) (1 trial)

Drugs in Other Trials (4)

nanohydroxyapetite (1 trial)

potassium nitrate (1 trial)

sodium fluoride (1 trial)

sodium monofluorphosphate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Hantavirus Infections (Phase 2)

Hantavirus Pulmonary Syndrome (Phase 2)

Unconsciousness (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 9
# of Trial APIs: 11